These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9673433)

  • 1. Inhibitory mechanisms of naloxone on human platelets.
    Sheu JR; Lee YM; Lee LW; Luk HN; Yen MH
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):585-91. PubMed ID: 9673433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism involved in the antiplatelet activity of naloxone in human platelets.
    Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH
    Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms involved in the antiplatelet activity of magnesium in human platelets.
    Sheu JR; Hsiao G; Shen MY; Fong TH; Chen YW; Lin CH; Chou DS
    Br J Haematol; 2002 Dec; 119(4):1033-41. PubMed ID: 12472585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa.
    Sheu JR; Hung WC; Lee YM; Yen MH
    Eur J Pharmacol; 1996 Dec; 318(2-3):469-75. PubMed ID: 9016940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
    Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
    Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms involved in the antiplatelet activity of midazolam in human platelets.
    Sheu JR; Hsiao G; Luk HN; Chen YW; Chen TL; Lee LW; Lin CH; Chou DS
    Anesthesiology; 2002 Mar; 96(3):651-8. PubMed ID: 11873041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets.
    Sheu JR; Kan YC; Hung WC; Ko WC; Yen MH
    Thromb Res; 1997 Nov; 88(3):259-70. PubMed ID: 9526946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Thromb Haemost; 1991 Oct; 66(4):489-93. PubMed ID: 1665595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
    Bode-Böger SM; Böger RH; Galland A; Frölich JC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet effect of demethyldiisoeugenol.
    Liao CH; Ko FN; Kuo YH; Teng CM
    Can J Physiol Pharmacol; 1996 Oct; 74(10):1111-6. PubMed ID: 9022830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
    Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
    Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms involved in the antiplatelet activity of ketamine in human platelets.
    Chang Y; Chen TL; Wu GJ; Hsiao G; Shen MY; Lin KH; Chou DS; Lin CH; Sheu JR
    J Biomed Sci; 2004; 11(6):764-72. PubMed ID: 15591773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF; Liu CZ; Ouyang CH; Teng CM
    Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
    Ding YA; Chou TC; Chern JW; Yen MH
    Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C.
    Sheu JR; Kan YC; Hung WC; Su CH; Lin CH; Lee YM; Yen MH
    Thromb Res; 1998 Oct; 92(2):53-64. PubMed ID: 9792112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation.
    Ko FN; Yeh LJ; Liang HC; Kuo SC; Teng CM
    J Pharm Pharmacol; 1996 Apr; 48(4):395-400. PubMed ID: 8794990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets.
    Liao CH; Ko FN; Kuo SC; Teng CM
    Jpn J Pharmacol; 1998 Feb; 76(2):141-8. PubMed ID: 9541276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
    Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
    Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.